ReviewCancers2026

Evolution of Immune Checkpoint Blockade in Metastatic NSCLC: A Narrative Review of Emerging Bispecific Antibodies and the Practical Challenges of Clinical Integration.

Jin Hyoung KangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.